No Data
Byhealth Co., Ltd's (SZSE:300146) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
The ten worst-performing consumer leaders of 2024.
Survival is the fundamental principle.
The review results of the 2024 By-health Co., Ltd. Scientific Nutrition Research Fund have been announced, and 6 projects have received funding.
Guangzhou, December 27, 2024 /PR Newswire/ -- On December 27, By-health Co., Ltd. announced the list of funding projects for the 2024 Scientific Nutrition Research Fund. After evaluation, a total of 6 projects will receive funding from the Fund, covering research directions such as nutrition and anti-aging, new material research and development, dried blood spot metabolomics detection technology, and the screening of natural functional ingredients. The Scientific Nutrition Research Fund is the successor to the By-health Research Fund, established in 2012, aimed at gathering scientific research strength and promoting fundamental and applied research centered on dietary nutritional supplements. To make the fund more inclusive and diverse.
The Past Three Years for Byhealth (SZSE:300146) Investors Has Not Been Profitable
By-health Co., Ltd. (300146.SZ): The company currently has no pet nutrition business.
On December 11, Gelonghui reported that By-health Co., Ltd. (300146.SZ) stated on the investor interaction platform that the company currently has no pet nutrition business.
Is Byhealth (SZSE:300146) A Risky Investment?
Byhealth Co., Ltd (SZSE:300146) Just Reported Earnings, And Analysts Cut Their Target Price
